Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$488 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$-18 Mln
ROE
-0.6 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
20.3
Industry P/E
44.78
EV/EBITDA
0
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$-0.9
Face value
--
Shares outstanding
21,596,500
CFO
$-38.80 Mln
EBITDA
$-49.21 Mln
Net Profit
$-52.39 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Soliton Inc (SOLY)
| -- | -- | -- | -- | -- | -- | -- |
|
BSE Sensex*
| -13.8 | -8.8 | -14.6 | -3.2 | 6.9 | 8.2 | 11.4 |
|
Company
|
2021
|
2020
|
|---|---|---|
|
Soliton Inc (SOLY)
| 194.0 | -30.1 |
|
BSE Sensex
| 22.0 | 15.8 |
|
BSE Sensex
| 22.0 | 15.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Soliton Inc (SOLY)
|
0.0 | 487.7 | 0.4 | -17.9 | -4,794.1 | -74.1 | -- | 20.3 |
| 7.9 | 5,388.2 | 6,552.2 | -530.2 | -4.1 | -9.2 | -- | 0.9 | |
| 278.3 | 7,510.1 | 2,583.2 | 759.9 | 25.2 | 10.8 | 10 | 1.0 | |
| 36.8 | 5,595.6 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.3 | |
| 112.8 | 6,549.6 | 507.4 | -187.7 | -36.2 | -26.4 | -- | 10.0 | |
| 76.1 | 4,954.3 | 1,541.6 | 233.6 | 21.6 | 21.4 | 22.3 | 4.5 | |
| 178.6 | 9,592.8 | 1,526.9 | -151.5 | 20.0 | -17.1 | 46.8 | 12.9 | |
| 330.4 | 12,964.3 | 1,403.7 | 177.7 | 14.7 | 13.8 | 72.9 | 9.0 | |
| 117.8 | 6,634.7 | 738.3 | 48.9 | 11.4 | 2.4 | 137 | 3.2 | |
| 32.1 | 13,716.9 | 6,178.4 | 626.5 | 13.0 | 11.9 | 22.5 | 2.6 |
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction,... fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc. Read more
Co-Founder & Exec. Chairman
Mr. Walter V. Klemp
Co-Founder & Exec. Chairman
Mr. Walter V. Klemp
Headquarters
Houston, TX
Website
The share price of Soliton Inc (SOLY) is $0.00 (NASDAQ) as of 27-Dec-2021 EDT. Soliton Inc (SOLY) has given a return of --% in the last 1 years.
Since, TTM earnings of Soliton Inc (SOLY) is negative, P/E ratio is not available.
The P/B ratio of Soliton Inc (SOLY) is 20.35 times as on 27-Dec-2021, a 578 premium to its peers’ median range of 3.00 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2020
|
-10.04
|
4.71
|
|
2019
|
-11.18
|
14.96
|
|
2018
|
--
|
--
|
|
2017
|
--
|
--
|
|
2016
|
--
|
--
|
The 52-week high and low of Soliton Inc (SOLY) are Rs -- and Rs -- as of 06-Apr-2026.
Soliton Inc (SOLY) has a market capitalisation of $ 488 Mln as on 27-Dec-2021. As per SEBI classification, it is a company.
Before investing in Soliton Inc (SOLY), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.